One hundred eighteen patients, aged between 65 and 87 years with mild-to-moderate
hypertension were given placebo or isradipine (1.25 to 5 mg twice daily, or 2.5 to 10 mg …

The aim of this study was to investigate the efficacy, tolerability, and safety of isradipine in
hypertensive diabetic patients. Twenty-eight patients (14 men and 14 women), of whom 15 …

The efficacy and safety of isradipine (PN 200‐110), a new dihydropyridine calcium
antagonist, was evaluated in 87 hypertensive patients in a placebo‐controlled, double …

The benefits of treating isolated systolic hypertension (ISH) have been established, but the
most appropriate choice of drug is still uncertain. For this reason, a sustained-release …

We compared the efficacy and tolerability of is‐radipine (ISR) and fosinopril (FOS) once‐a‐
day administration in 17 outpatients, 9 men and 8 women, aged 35–65 years (mean±SD …

Isradipine is a new dihydropyridine calcium antagonist with a high degree of selectivity for
the coronary, cerebral, and skeletal muscle vasculature. The drug has minimal depressant …

After three months of treatment with isradipine, 20 patients with mild hypertension had
reduced their resting blood pressure (BP) from 157/103 to 132/85 mm Hg and their BP …

A 6-week open study of the introduction of isradipine treatment was conducted in general
practice in Hong Kong. 303 Chinese patients with mild to moderate hypertension entered …

Over 200 hypertensive patients were recruited by 37 general practitioners into a single-blind
12-week study to assess the efficacy, tolerability, and safety of isradipine as an …

Twenty-four-hour ambulatory blood pressure (BP) monitoring allows the physician to follow
the course of blood pressure of a patient at the worksite, at home, and during sleep. All these …